Concurrent Investment Advisors LLC Raises Stock Holdings in Medical Properties Trust, Inc. $MPW

Concurrent Investment Advisors LLC boosted its position in shares of Medical Properties Trust, Inc. (NYSE:MPW) by 20.8% during the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 21,306 shares of the real estate investment trust’s stock after purchasing an additional 3,671 shares during the quarter. Concurrent Investment Advisors LLC’s holdings in Medical Properties Trust were worth $92,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors also recently bought and sold shares of the company. Apollon Wealth Management LLC purchased a new position in Medical Properties Trust during the 2nd quarter worth $47,000. Inspire Investing LLC increased its holdings in Medical Properties Trust by 58.2% during the 2nd quarter. Inspire Investing LLC now owns 90,844 shares of the real estate investment trust’s stock worth $392,000 after purchasing an additional 33,419 shares during the period. Commerzbank Aktiengesellschaft FI increased its holdings in Medical Properties Trust by 18.7% during the 2nd quarter. Commerzbank Aktiengesellschaft FI now owns 188,287 shares of the real estate investment trust’s stock worth $812,000 after purchasing an additional 29,641 shares during the period. Ameritas Advisory Services LLC increased its holdings in Medical Properties Trust by 2.4% during the 2nd quarter. Ameritas Advisory Services LLC now owns 238,313 shares of the real estate investment trust’s stock worth $1,027,000 after purchasing an additional 5,564 shares during the period. Finally, Wilsey Asset Management Inc. increased its holdings in Medical Properties Trust by 6.1% during the 2nd quarter. Wilsey Asset Management Inc. now owns 4,927,568 shares of the real estate investment trust’s stock worth $21,238,000 after purchasing an additional 281,591 shares during the period. 71.79% of the stock is currently owned by hedge funds and other institutional investors.

Medical Properties Trust Trading Down 1.4%

Shares of NYSE:MPW opened at $5.15 on Wednesday. Medical Properties Trust, Inc. has a 12-month low of $3.51 and a 12-month high of $6.34. The business’s fifty day simple moving average is $4.81 and its 200-day simple moving average is $4.71. The company has a market capitalization of $3.09 billion, a PE ratio of -2.15 and a beta of 1.39. The company has a current ratio of 2.76, a quick ratio of 2.76 and a debt-to-equity ratio of 2.00.

Medical Properties Trust (NYSE:MPW) last posted its quarterly earnings data on Thursday, July 31st. The real estate investment trust reported $0.14 earnings per share for the quarter, missing analysts’ consensus estimates of $0.15 by ($0.01). The business had revenue of $240.36 million during the quarter, compared to analyst estimates of $231.90 million. Medical Properties Trust had a negative return on equity of 28.80% and a negative net margin of 155.20%.The firm’s revenue for the quarter was down 9.8% compared to the same quarter last year. During the same period in the previous year, the business earned $0.23 EPS. As a group, equities research analysts predict that Medical Properties Trust, Inc. will post 0.78 earnings per share for the current fiscal year.

Medical Properties Trust Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, October 9th. Stockholders of record on Thursday, September 11th were given a $0.08 dividend. The ex-dividend date of this dividend was Thursday, September 11th. This represents a $0.32 dividend on an annualized basis and a dividend yield of 6.2%. Medical Properties Trust’s dividend payout ratio (DPR) is presently -13.39%.

Analysts Set New Price Targets

Several research analysts have commented on the company. Royal Bank Of Canada reduced their price objective on Medical Properties Trust from $5.00 to $4.50 and set a “sector perform” rating on the stock in a report on Monday, June 30th. Zacks Research upgraded Medical Properties Trust from a “strong sell” rating to a “hold” rating in a report on Wednesday, August 20th. Wells Fargo & Company reduced their price objective on Medical Properties Trust from $5.00 to $4.50 and set an “underweight” rating on the stock in a report on Wednesday, August 27th. Weiss Ratings restated a “sell (d-)” rating on shares of Medical Properties Trust in a report on Wednesday, October 8th. Finally, Wall Street Zen downgraded Medical Properties Trust from a “hold” rating to a “sell” rating in a report on Saturday, July 5th. One equities research analyst has rated the stock with a Buy rating, four have issued a Hold rating and two have given a Sell rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Reduce” and a consensus target price of $5.40.

Medical Properties Trust Company Profile

Medical Properties Trust, Inc is a self-advised real estate investment trust formed in 2003 to acquire and develop net-leased hospital facilities. From its inception in Birmingham, Alabama, the Company has grown to become one of the world's largest owners of hospital real estate with 441 facilities and approximately 44,000 licensed beds as of September 30, 2023.